{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T08:52:19Z","timestamp":1762419139576,"version":"build-2065373602"},"reference-count":39,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Cl\u00ednica Espa\u00f1ola (English Edition)"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.rceng.2020.04.013","type":"journal-article","created":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T19:55:31Z","timestamp":1620762931000},"page":"497-508","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Assessment of the quality of antibiotics prescription in a regional health system"],"prefix":"10.1016","volume":"221","author":[{"given":"P.","family":"Rojas Garc\u00eda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Anto\u00f1anzas Villar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2017","series-title":"D\u00eda europeo para el uso prudente de los antibi\u00f3ticos, 2017. Declaraci\u00f3n de Vytenis Andriukaitis, comisario de salud y seguridad alimentaria, y Carlos Moedas, comisario de investigaci\u00f3n, ciencia e innovaci\u00f3n","author":"Comisi\u00f3n Europea","key":"10.1016\/j.rceng.2020.04.013_bib0200"},{"year":"2015","series-title":"Strategic action plan to reduce the risk of selection and dissemination of antibiotic resistance","author":"Agencia espa\u00f1ola de medicamentos y productos sanitarios","key":"10.1016\/j.rceng.2020.04.013_bib0205"},{"year":"2020","series-title":"Campa\u00f1as en Europa","author":"European Centre for Disease Prevention and Control (ECDC)","key":"10.1016\/j.rceng.2020.04.013_bib0210"},{"year":"2017","series-title":"Plan nacional frente a la resistencia a los antibi\u00f3ticos","author":"Ministerio de sanidad, consumo y bienestar social","key":"10.1016\/j.rceng.2020.04.013_bib0215"},{"key":"10.1016\/j.rceng.2020.04.013_bib0220","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0025-7753(02)72453-6","article-title":"Evoluci\u00f3n del consumo de antibi\u00f3ticos en Espa\u00f1a, 1985\u20132000","volume":"118","author":"L\u00e1zaro","year":"2002","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.rceng.2020.04.013_bib0225","first-page":"44","article-title":"Variabilidad en la prescripci\u00f3n de antibi\u00f3ticos en la provincia de \u00c1vila","volume":"20","author":"Ripoll","year":"2007","journal-title":"Rev Esp Quimioter"},{"key":"10.1016\/j.rceng.2020.04.013_bib0230","first-page":"55","article-title":"An\u00e1lisis del gasto derivado de la prescripci\u00f3n de antibi\u00f3ticos en la poblaci\u00f3n pedi\u00e1trica de Castilla y Le\u00f3n","volume":"10","author":"V\u00e1zquez","year":"2008","journal-title":"Rev Pediatr Aten Primaria"},{"key":"10.1016\/j.rceng.2020.04.013_bib0235","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.aprim.2010.04.015","article-title":"Alta exposici\u00f3n a antibi\u00f3ticos en la poblaci\u00f3n y sus diferencias por g\u00e9nero y edad","volume":"43","author":"Serna","year":"2011","journal-title":"Aten Primaria"},{"key":"10.1016\/j.rceng.2020.04.013_bib0240","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.eimc.2012.03.004","article-title":"Prescripci\u00f3n extrahospitalaria de antibi\u00f3ticos en Arag\u00f3n y sus diferencias por g\u00e9nero y edad","volume":"30","author":"Lallana-Alvarez","year":"2012","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.rceng.2020.04.013_bib0245","first-page":"27","article-title":"An\u00e1lisis del uso ambulatorio de antibi\u00f3ticos en los hospitales generales de Asturias entre 2006 y 2015","volume":"31","author":"S\u00e1nchez-N\u00fa\u00f1ez","year":"2018","journal-title":"Rev Esp Quimioter"},{"key":"10.1016\/j.rceng.2020.04.013_bib0250","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1136\/qshc.2006.021121","article-title":"European surveillance of antimicrobial consumption (ESAC): quality indicators for outpatient antibiotic use in Europe","volume":"16","author":"Coenen","year":"2007","journal-title":"Qual Saf Health Care"},{"year":"2017","series-title":"Plan de acci\u00f3n europeo \u00abUna sola salud\u00bb para luchar contra la resistencia a los antimicrobianos","author":"EUR-Lex: Derecho de la UE","key":"10.1016\/j.rceng.2020.04.013_bib0255"},{"key":"10.1016\/j.rceng.2020.04.013_bib0260","doi-asserted-by":"crossref","first-page":"vi47","DOI":"10.1093\/jac\/dkr457","article-title":"European surveillance of antimicrobial consumption (ESAC): outpatient quinolone use in Europe (1997\u20132009)","volume":"66","author":"Adriaenssens","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.rceng.2020.04.013_bib0265","doi-asserted-by":"crossref","first-page":"E3463","DOI":"10.1073\/pnas.1717295115","article-title":"Global increase and geographic convergence in antibiotic consumption between 2000 and 2015","volume":"115","author":"Klein","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"year":"2019","series-title":"La implementaci\u00f3n, el gran reto del Plan nacional frente a la resistencia a los antibi\u00f3ticos","author":"El Global","key":"10.1016\/j.rceng.2020.04.013_bib0270"},{"year":"2020","series-title":"Consumos antibi\u00f3ticos sector comunitario","author":"Plan nacional frente a la resistencia a los antibi\u00f3ticos","key":"10.1016\/j.rceng.2020.04.013_bib0275"},{"year":"2020","series-title":"ATC\/DDD Index 2020","author":"Organizaci\u00f3n Mundial de la Salud","key":"10.1016\/j.rceng.2020.04.013_bib0280"},{"year":"2012","series-title":"Real Decreto Ley 16\/2012, de 20 de abril, de Medidas Urgentes para Garantizar la Sostenibilidad del Sistema Nacional de Salud y mejorar la calidad y seguridad de sus prestaciones","key":"10.1016\/j.rceng.2020.04.013_bib0285"},{"key":"10.1016\/j.rceng.2020.04.013_bib0290","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1136\/qhc.12.2.122","article-title":"Using routine comparative data to assess the quality of health care: understanding and avoiding common pitfalls","volume":"12","author":"Powell","year":"2003","journal-title":"Qual Saf Health Care"},{"key":"10.1016\/j.rceng.2020.04.013_bib0295","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1136\/qhc.0100152","article-title":"Systematic review of studies of quality of clinical care in general practice in the UK, Australia and New Zealand","volume":"10","author":"Seddon","year":"2001","journal-title":"Qual Health Care"},{"key":"10.1016\/j.rceng.2020.04.013_bib0300","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/jac\/dkp135","article-title":"European Surveillance of Antimicrobial Consumption (ESAC): outpatient parenteral antibiotic treatment in Europe","volume":"64","author":"Coenen","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.rceng.2020.04.013_bib0305","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s10198-018-1021-z","article-title":"The economics of antibiotic resistance: a claim for personalised treatments","volume":"20","author":"Anto\u00f1anzas","year":"2019","journal-title":"Eur J Health Econ"},{"year":"2018","series-title":"Resistencia a los antibi\u00f3ticos. Datos y cifras","author":"Organizaci\u00f3n Mundial de la Salud","key":"10.1016\/j.rceng.2020.04.013_bib0310"},{"key":"10.1016\/j.rceng.2020.04.013_bib0315","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1136\/bmjqs.2010.049049","article-title":"The ESAC Project Group European Surveillance of Antimicrobial Consumption (ESAC): disease-specific quality indicators for outpatient antibiotic prescribing","volume":"20","author":"Adriaenssens","year":"2011","journal-title":"BMJ Qual Saf"},{"key":"10.1016\/j.rceng.2020.04.013_bib0320","doi-asserted-by":"crossref","first-page":"vi71","DOI":"10.1093\/jac\/dkr459","article-title":"ESAC Project Group European Surveillance of Antimicrobial Consumption (ESAC): quality appraisal of antibiotic use in Europe","volume":"66","author":"Adriaenssens","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.rceng.2020.04.013_bib0325","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/S1473-3099(15)00149-8","article-title":"Out-of-pocket health expenditures and antimicrobial resistance in low-income and middle-income countries: an economic analysis","volume":"15","author":"Alsan","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.rceng.2020.04.013_bib0330","first-page":"73","article-title":"Normas y estrategias para el uso racional de antibi\u00f3ticos","volume":"8","author":"Vera","year":"2012","journal-title":"Rev Med La Paz"},{"key":"10.1016\/j.rceng.2020.04.013_bib0335","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1093\/jac\/dkm032","article-title":"Age- and gender-specific antibacterial prescribing in Norway","volume":"59","author":"Blix","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.rceng.2020.04.013_bib0340","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.eimc.2012.07.003","article-title":"Uso de los antibi\u00f3ticos en la comunidad: la prevalencia como punto de partida","volume":"30","author":"Campos","year":"2012","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.rceng.2020.04.013_bib0345","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/jac\/dkm248","article-title":"Surveillance of outpatient antibiotic consumption in Spain according to sales data and reimbursement data","volume":"60","author":"Campos","year":"2007","journal-title":"J Antimicrob Chemother"},{"year":"2019","series-title":"Espa\u00f1a se acerca m\u00e1s a la media europea en consumo de antibi\u00f3ticos","author":"El Global","key":"10.1016\/j.rceng.2020.04.013_bib0350"},{"year":"2016","series-title":"Public Opinion. Antimicrobial Resistance (in the EU)","author":"European Commission","key":"10.1016\/j.rceng.2020.04.013_bib0355"},{"year":"2019","series-title":"Nota de prensa. Los antibi\u00f3ticos NO valen para todo","author":"Ministerio de sanidad, consumo y bienestar social","key":"10.1016\/j.rceng.2020.04.013_bib0360"},{"key":"10.1016\/j.rceng.2020.04.013_bib0365","first-page":"30363","article-title":"Perfil de las solicitudes de antibi\u00f3ticos en farmacia comunitaria con receta privada y prescripci\u00f3n irregular","author":"Carbajal","year":"2019","journal-title":"Semergen"},{"key":"10.1016\/j.rceng.2020.04.013_bib0370","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/jac\/dky440","article-title":"Magnitude and determinants of antibiotic dispensing without prescription in Spain: a simulated patient study","volume":"74","author":"Zapata-Cachafeiro","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.rceng.2020.04.013_bib0375","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1093\/jac\/dky319","article-title":"Determinants of antibiotic dispensing without prescription: a systematic review","volume":"73","author":"Servia-Dopazo","year":"2018","journal-title":"J Antimicrob Chemother"},{"year":"2018","series-title":"Infectious diseases & public health. Rates by country","author":"European Centre for Disease Prevention and Control","key":"10.1016\/j.rceng.2020.04.013_bib0380"},{"key":"10.1016\/j.rceng.2020.04.013_bib0385","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.cmi.2019.07.009","article-title":"Outcomes of the PIRASOA programme, an antimicrobial stewardship programme implemented in hospitals of the Public Health System of Andalusia, Spain: an ecologic study of time-trend analysis","volume":"26","author":"Rodr\u00edguez-Ba\u00f1o","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.rceng.2020.04.013_bib0390","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1473-3099(19)30573-0","article-title":"Long-term impact of an educational antimicrobial stewardship programme in primary care on infections caused by extended-spectrum (-lactamase-producing Escherichia coli in the community: an interrupted time-series analysis)","volume":"20","author":"Pe\u00f1alva","year":"2019","journal-title":"Lancet Infect Dis"}],"container-title":["Revista Cl\u00ednica Espa\u00f1ola (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S225488742100062X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S225488742100062X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T08:48:31Z","timestamp":1762418911000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S225488742100062X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S225488742100062X"],"URL":"https:\/\/doi.org\/10.1016\/j.rceng.2020.04.013","relation":{},"ISSN":["2254-8874"],"issn-type":[{"type":"print","value":"2254-8874"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of the quality of antibiotics prescription in a regional health system","name":"articletitle","label":"Article Title"},{"value":"Revista Cl\u00ednica Espa\u00f1ola (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rceng.2020.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.rce.2020.04.015","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Espa\u00f1a, S.L.U. and Sociedad Espa\u00f1ola de Medicina Interna (SEMI). All rights reserved.","name":"copyright","label":"Copyright"}]}}